Lung Cancer Diagnostics Market Size Is Predicted To Reach A Valuation Of USD 3,644.6 Million By 2024: Grand View Research Inc.

San Francisco, 8 April 2019: The Report Lung Cancer Diagnostics Market Analysis By Type (Small Cell Lung Cancer, Non-small Cell Lung Cancer), By Test (Imaging Test, Biopsy, Sputum Cytology, Molecular Testing), And Segment Forecasts To 2024

The global lung cancer diagnostics market is expected to reach USD 3,644.6 million by 2024, according to a new report by Grand View Research Inc. The development of lung cancer-specific biomarkers is one of the primary factors for the growth of the lung cancer diagnostics market over the forecast period. These diagnostic tools facilitate the personalized treatment approach of lung malignancies. 

Various biomarkers are present in the research pipeline. For instance, in November 2015, Epigenomics AG announced the launch of a new blood-based test using DNA methylation biomarkers, the development of which is underway. The initial results of this test revealed a promising outcome in the early diagnosis of lung cancer. 

Furthermore, various awareness programs focusing on lung cancer and its associated symptoms are initiated in an attempt to elevate the screening and diagnosis rates inindividuals at a high risk of developing lung malignancies. For instance, November is considered as a lung cancer awareness month across the UK, which is supported by the Roy Castle Lung Cancer Foundation. 

Access Research Report of Lung Cancer Diagnostics Market @ http://www.grandviewresearch.com/industry-analysis/lung-cancer-diagnostics-market

Further key findings from the study suggest:

·       The small cell lung cancer segment accounted for around 15% market share in 2015. This is an aggressive subtype of the lung malignancies, which has proven to be fatal within a short period of time if left undiagnosed.

·       Non-small cell lung cancer was identified as the largest segment in 2015 with revenue of over USD 1,300.0 million. This is majorly due to the availability of novel lung cancer diagnostics that facilitate the detection of large tumor growths.

·       The imaging tests segment was identified as the largest revenue generating segment in 2015 with a market share of around 50%. Major factors responsible for the large market share include the frequent use of various imaging techniques such as CT scan, X-ray, and MRI in the detection of lung malignancies coupled with the increased availability of the diagnostic tools.

·       The molecular testing segment is expected to grow at a profitable rate of around 10% over the forecast period. The introduction of novel molecular testing techniques coupled with the increasing number of investments to support the research and development efforts for the development of biomarker-based molecular testing in lung cancer detection is expected to foster the demand of this segment over the forecast period.

·       In 2015, North America accounted for the largest revenue share of over 30% majorly due to supportive government policies in the region coupled with the availability of technology-enabled lung cancer diagnostics

·       Asia Pacific region is expected to reach a revenue share of over 28% by 2024. Major factors responsible for the growth include the constantly improving healthcare infrastructure, the growing awareness of the disease symptoms, and a wide base of unmet clinical needs in the developing countries in the region.

·       Major players of this market include bioMérieux, Roche Diagnostics, Qiagen N.V., Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, Janssen, AstraZeneca plc, and Sanofi S.A.

·       Novel product launches in the lung cancer diagnostics product portfolio is one of the major strategic initiatives adopted by the market players. For instance, Orion genomics is involved in the development of novel biomarkers for lung cancer diagnosis. Allegro Diagnostics is involved in the development and commercialization of pulmonary genomics-based lung cancer diagnostics. 

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/clinical-diagnostics

 Grand View Research has segmented the global lung cancer diagnostics market on the basis of type, test, and region:

Global Lung Cancer Diagnostics Type Outlook (Revenue, USD Million, 2016 - 2024)

·         Small Cell Lung Cancer

·         Non-small Cell Lung Cancer

Global Lung Cancer Diagnostics Test Outlook (Revenue, USD Million, 2016 - 2024)

·         Imaging Test

·         Biopsy

·         Sputum Cytology

·         Molecular Test

·         Others

Lung Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2022)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Lung Cancer Diagnostics Market@ https://www.grandviewresearch.com/press-release/global-lung-cancer-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

In-Memory Analytics Market to Surpass USD 6.62 Billion by 2025: Grand View Research Inc.

San Francisco, 8 April 2019: The Report In-Memory Analytics Market By Application, By End-use (SMEs, Large Enterprises), By Vertical (BFSI, Retail, Defense, Healthcare, Manufacturing, ITES), By Region, And Segment Forecasts, 2018 - 2025

The global in-memory analytics market is expected to touch USD 6.62 billion by 2025, according to a study conducted by Grand View Research, Inc. The advancements in technology and the need for cost efficiency have increased the adoption of in-memory analytics. In-memory analytics includes various applications such as customer experience management, design & innovation, operational optimization, marketing management, real-time analysis & decision-making, and others. These solutions not only enable enterprises to increase their operational efficiency, but they also assist them in reducing expenses.

For the in-memory analytics market to work successfully, seamless connectivity is one of the most important prerequisites. The presence of a strong wireless connectivity infrastructure in regions such as North America has facilitated the widespread adoption of in-memory analytics. Hence, this regional market is expected to see substantial growth in 2017. Additionally, the presence of prominent in-memory analytics market companies such as SAS Institute, Kognitio, Qlik, SAP SE, and IBM, among others, is estimated to boost the growth prospects of the in-memory analytics market.

While the rising number of in-memory analytics devices are propelling the market growth, there has also been significant concerns over data privacy and data security. As there has been a significant increase in cyber-attacks around the world, the need to safeguard the end user from a potential attack would play an essential role in determining the growth of the in-memory analytics market.

Access Research Report of In-Memory Analytics Market @ https://www.grandviewresearch.com/industry-analysis/in-memory-analytics-market

Further key findings from the study suggest: 

·       Healthcare is the fastest growing vertical at a CAGR of 25.0%. The need for providing real-time insights would prove to be essential for the growth of the segment.

·       Small & Medium Enterprises (SMEs) are expected to grow at a higher CAGR of 29.0% over the forecast period.

·       Benefits such as cost optimization, operations management, and strategic-decision making are expected to drive the growth of the in-memory analytics market.

·       Customer experience management enabling customers with customized products and services, is expected to grow at the CAGR of 24.8% over the forecast period.

·       The North American region is currently leading in the market and the trend is expected to continue over the forecast period.

·       The primary reasons behind the growth of North American region are the early adoption of the technology and the presence of leading market players.

·       Prominent players operating in the in-memory analytics market include Oracle, SAP SE, MicroStrategy Inc., International Business Machines (IBM), Software AG, among others.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global in-memory analytics market on the basis of application, end-use, vertical and region:

Application Outlook (Revenue, USD Million; 2014 - 2025)

·         Customer Experience Management

·         Design & Innovation

·         Operational Optimization

·         Marketing Management

·         Real-Time Analysis and Decision-Making

·         Others

End-Use Outlook (Revenue, USD Million; 2014 - 2025)

·         SMEs

·         Large Enterprises

Vertical Outlook (Revenue, USD Million; 2014 - 2025)

·         BFSI

·         Retail & E-commerce

·         Government & Defense

·         Healthcare

·         Manufacturing

·         Telcos & ITES

·         Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa (MEA)

Access Press Release of In-Memory Analytics Market@ https://www.grandviewresearch.com/press-release/global-in-memory-analytics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Therapeutic Bed Market to Record an Exponential CAGR by 2024: Grand View Research Inc.

San Francisco, 8 April 2019: The Report Therapeutic Bed Market Analysis By Product (Clinical, Household, Accessories), By Type (Acute Care, Critical Care, Long-term) And Segment Forecasts To 2024

The global therapeutic bed market is expected to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base coupled with the rising cases of obesity, chronic conditions, and viral infections are expected to boost market growth over the forecast period. 

As per the U.S. Bureau of Labor Statistics, the rank of home health aides and personal care aides is expected to increase to 13.0 million in 2020 (a 70.0% increase from 2010), thereby increasing the demand for home care. This growth is expected to increase the sale of household therapeutic beds and propel growth over the forecast period. Considering that the treatment costs at home are lower than other settings, many patients are now preferring home healthcare, thus, ultimately increasing the demand for therapeutic beds in these facilities. 

Another macro factor promoting the Therapeutic Bed Market is the increase in the volume of healthcare settings across the globe. With the help of this grant, 17 new hospitals and the expansion of 137 hospitals and primary health centers are anticipated, thereby increasing the sale of therapeutic beds. Similarly, in Qatar, the number of hospital beds is expected to rise from 4,980 in 2013 to 5,725 in 2018. These expansions are expected to create new avenues for market players to capitalize on. 

Access Research Report of Therapeutic Bed Market @ http://www.grandviewresearch.com/industry-analysis/therapeutic-beds-market

Further key findings from the study suggest:

·       The household bed segment is identified as the fastest growing. The growing penetration of home healthcare services for preventive care, post-operative care, and for long-term chronic therapies are expected to drive the growth over the forecast period.

·       Clinical beds have been further sub-segmented into regular, ICU, pediatric, birthing, bariatric, low air loss, and other beds. Bariatric beds are expected to gain the highest application in regions such as the U.S., Canada, the UK, and Germany due to the rising number of obese population.

·       North America is expected to dominate the overall market throughout the forecast period, owing to the presence of well-developed primary, secondary, tertiary care hospitals, the presence of a well-developed reimbursement network, government funding, and high public and private expenditure in the hospitals sector

·       Asia Pacific is anticipated to be the fastest growing region. The market is expected to grow at a CAGR of about 7.0% over the forecast period. The hospital to beds ratio is below the WHO standards in several Asia Pacific countries and the governments are investing significant resources to improve the healthcare infrastructure in this region.

·       Key players of the industry include Invacare Corporation, Hill-Rom, Inc., Stryker Corporation, ArjoHuntleigh, Gendron, Inc., Hard Manufacturing Co., Bakare, Medline Industries, Sunrise Medical, and GF Health Products, Inc. Most of these companies have been in the business for over a decade and are bringing in expertise and technological advancement that are expected to help them sustain over the forecast period.

·       In order to curb competition, major market players are working towards the acquisition of emerging entrants. For instance, in January 2015, Stryker Corporation acquired the assets of CHG hospital Beds, Inc., a privately held company to enhance the low height bed designs portfolio. 

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented Therapeutic Bed Market on the basis of products, type, and region

Global Therapeutic Beds Product Outlook (Revenue, USD Million, 2014 - 2024)

·         Clinical Beds

·         Household Beds

·         Accessories

Global Therapeutic Beds Type Outlook (Revenue, USD Million, 2014 - 2024) 

·         Acute Care

·         Critical Care

·         Long-term

Therapeutic Beds Regional Outlook (Revenue, USD Million, 2014 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Therapeutic Bed Market@ https://www.grandviewresearch.com/press-release/global-therapeutic-bed-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Sterilization Equipment Market Expected To Trigger A Revenue To USD 9.8 Billion By 2025: Grand View Research, Inc.

San Francisco, 5 April 2019: The Report Sterilization Equipment Market Analysis By Technique (Heat, Low Temperature, Filtration, Radiation, Liquid), By End Use (Hospitals, Pharmaceutical, Medical Devices, Clinical Laboratories), And Segment Forecasts, 2018 - 2025

The global sterilization equipment market is expected to reach USD 9.8 billion by 2025, according to a new study by Grand View Research Inc. Increasing number of hospital stays and growing awareness amongst the patient population regarding hospital-acquired infections (HAI) are propelling the market growth at a global level. Sterilization of medical devices is significant in order to prevent the spread of diseases such as AIDS.

Furthermore, proper sterilization of medical devices also prevents additional surgeries required to treat infections caused by the use of unsterilized devices, thus reducing cost and life-threatening complications. According to various research studies and statistics, sterilization shows almost 100% effective results with the least rate of contamination in hospitals and other medical institutions.

Access Research Report of Sterilization Equipment Market @ http://www.grandviewresearch.com/industry-analysis/sterilization-equipment-market

Further Key Findings from the Study Suggest:

·       Heat sterilization technique dominated the overall market in 2015, as it is the most widely used method for the sterilization of maximum medical equipment

·       In addition, glassware such as flasks, petri dishes, pipette, burette, and glass syringes are the most compatible with heat sterilization

·       Low-temperature sterilization is anticipated to grow at the highest CAGR during the forecast period since the technique is used to sterilize heat-sensitive and moisture-sensitive loads with high efficiency as it destroys even the microorganisms

·       Hospitals segment occupied the largest share in 2014. The segment is also expected to witness the highest growth rate during the forecast period as most of the medical equipment find its application in hospitals.

·       North America dominated the segment with the largest revenue share in 2015 due to greater technological advancement, growing awareness, and highly developed healthcare infrastructure.

·       Increasing number of surgical procedures in hospitals is aggressively propelling the demand for sterilization equipment in North America, which is expected to boost the growth in North America

·       Asia Pacific is anticipated to show a significant growth during the forecast period, mainly due to increasing government initiatives, large pool of patient population, and increasing incidence of hospital-acquired infections

·       Some of the major companies operating in this market are STERIS plc; Getinge AB, Advanced Sterilization Products Services, Inc.; 3M; Belimed; Cantel Medical; MATACHANA GROUP; Sterigenics International LLC; and TSO₃.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the sterilization equipment market on the basis of technique, end use, and region:

Sterilization equipment Technique Outlook (Revenue, USD Million, 2014 - 2025)

·         Heat sterilization

·         Low-temperature sterilization

·         Filtration sterilization

·         Radiation sterilization

·         Liquid sterilization

Sterilization equipment End-user Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Pharmaceutical companies

·         Medical devices companies

·         Clinical laboratories/research centers

·         Others

Sterilization equipment Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Sterilization Equipment Market@ https://www.grandviewresearch.com/press-release/global-sterilization-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com